| Active ingredient (INN) | Brivaracetam |
|---|---|
| Brand names | Apo-Brivaracetam |
| ATC level 5 | N03AX23 |
| ATC level 4 | N03AX |
| Therapeutic category | Auto-created by Health Canada — Drug Shortages Database scraper |
| Controlled substance | No |
| Marketing-authorisation holders | PAI Holdings, LLC dba PAI Pharma, UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia, APOTEX CORP., Ascend Laboratories, LLC |
| Registrations on file | 13 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Brivaracetam | 10mg/mL | solution | 🇺🇸 US | PAI Holdings, LLC dba PAI Pharma | Active |
| Brivaracetam | 50mg/5mL | injection | 🇺🇸 US | PAI Holdings, LLC dba PAI Pharma | Active |
| BRIVIACT brivaracetam | 10mg | — | 🇦🇺 AU | UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia | Active |
| BRIVIACT brivaracetam | 25mg | — | 🇦🇺 AU | UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia | Active |
| BRIVIACT brivaracetam | 50mg | — | 🇦🇺 AU | UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia | Active |
| BRIVIACT brivaracetam | 75mg | — | 🇦🇺 AU | UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia | Active |
| BRIVIACT brivaracetam | 100mg | — | 🇦🇺 AU | UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia | Active |
| Brivaracetam | 10mg/1 | tablet | 🇺🇸 US | APOTEX CORP. | Active |
| Brivaracetam | 25mg/1 | tablet | 🇺🇸 US | APOTEX CORP. | Active |
| Brivaracetam | 50mg/1 | tablet | 🇺🇸 US | APOTEX CORP. | Active |
| Brivaracetam | 75mg/1 | tablet | 🇺🇸 US | APOTEX CORP. | Active |
| Brivaracetam | 100mg/1 | tablet | 🇺🇸 US | APOTEX CORP. | Active |
| Brivaracetam Oral Solution | 10mg/mL | solution | 🇺🇸 US | Ascend Laboratories, LLC | Active |